UL

Unilever
D

UL

Arincen63/100B

Unilever return on equity (ROE)

Unilever's return on equity is 32.28%: net income of 5.23B EUR over the last twelve months on shareholders' equity of 16.19B EUR.

Today
32.28%
Average, 5 years
34.47%
Low, 5 years
28.73%
High, 5 years
43.02%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 5.23B ÷ 16.19B = 32.28%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

Why is Unilever's return on equity so high?

Net margin
18.7%
profit on each dollar of sales
Asset turnover
0.72×
sales on each dollar of assets
Equity multiplier
4.54×
assets on each dollar of equity
Return on equity
61.0%
FY2025
  • FY202518.7% × 0.72 × 4.54 = 61.0%
  • FY20249.5% × 0.76 × 3.99 = 28.7%
  • FY202310.9% × 0.79 × 4.16 = 35.8%
  • FY202212.7% × 0.77 × 4.09 = 40.2%
  • FY202111.5% × 0.70 × 4.39 = 35.4%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today32.28%5.23B16.19B
FY202531 Dec 202561.00%9.47B15.52B
FY202431 Dec 202428.73%5.74B19.99B
FY202331 Dec 202335.84%6.49B18.10B
FY202231 Dec 202240.18%7.64B19.02B
FY202131 Dec 202135.36%6.05B17.11B
FY202031 Dec 202036.56%5.58B15.27B
FY201931 Dec 201942.64%5.63B13.19B
FY201831 Dec 201880.96%9.37B11.57B
FY201731 Dec 201744.19%6.02B13.63B
FY201631 Dec 201631.70%5.18B16.36B
FY201531 Dec 201531.80%4.91B15.44B
FY201431 Dec 201437.88%5.17B13.65B
FY201331 Dec 201333.76%4.84B14.34B
FY201231 Dec 201232.64%4.95B15.16B
FY201131 Dec 201132.34%4.62B14.29B
FY201031 Dec 201031.74%4.60B14.49B
FY200931 Dec 200930.33%3.66B12.07B
FY200831 Dec 200872.04%7.17B9.95B
FY200731 Dec 200742.34%5.25B12.39B
FY200631 Dec 200648.16%5.41B11.23B
FY200531 Dec 200560.69%5.07B8.36B
FY200431 Dec 200458.36%4.24B7.26B
FY200331 Dec 200390.93%3.81B4.19B
FY200231 Dec 2002104.51%4.91B4.69B
FY200131 Dec 200125.55%1.84B7.20B
FY200031 Dec 200041.88%5.21B12.45B
FY199931 Dec 199959.76%4.56B7.63B
FY199831 Dec 199890.45%4.18B4.62B
FY199731 Dec 199732.47%3.58B11.02B
FY199631 Dec 199656.45%3.95B7.00B
FY199531 Dec 199545.81%3.04B6.65B
FY199431 Dec 199449.44%3.22B6.51B
FY199331 Dec 199342.01%2.57B6.11B
FY199231 Dec 199247.29%2.66B5.63B
FY199131 Dec 199158.68%2.79B4.76B
FY199031 Dec 199032.73%1.29B3.94B
FY198931 Dec 198937.27%1.34B3.60B
FY198831 Dec 198826.60%1.29B4.84B
FY198731 Dec 198726.34%1.12B4.26B
FY198631 Dec 198617.91%917.60M5.12B
FY198531 Dec 198515.58%836.61M5.37B

Figures in EUR. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about Unilever's ROE

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.